MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹207 Cr | ₹230 Cr | ₹237 Cr | ₹99 Cr | ₹179 Cr |
What is the latest Cash Flow from Operating Activities ratio of MARKSANS PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹207 Cr |
| Mar2024 | ₹230 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹99 Cr |
| Mar2021 | ₹179 Cr |
How is Cash Flow from Operating Activities of MARKSANS PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹207 Cr | -10.30 | |
| Mar2024 | ₹230 Cr | -2.95 | |
| Mar2023 | ₹237 Cr | 139.19 | |
| Mar2022 | ₹99 Cr | -44.42 | |
| Mar2021 | ₹179 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,770.1 Cr | -1.5% | 2.3% | -23% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -1.5% |
2.3% |
-23% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses